Synthetic peptides outside the spike protein heptad repeat regions as potent inhibitors of SARS-associated coronavirus - PubMed (original) (raw)

Yi Guan, Ming-Liang Hez, Hongzhe Sun, Lanying Du, Ying Zheng, Kin-Ling Wong, Honglin Chen, Ying Chen, Linyu Lu, Julian A Tanner, Rory M Watt, Neri Niccolai, Andrea Bernini, Ottavia Spiga, Patrick C Y Woo, Hsiang-fu Kung, Kwok-Yung Yuen, Jian-Dong Huang

Affiliations

PMID: 15918330

Synthetic peptides outside the spike protein heptad repeat regions as potent inhibitors of SARS-associated coronavirus

Bo-Jion Zheng et al. Antivir Ther. 2005.

Abstract

A novel severe acute respiratory syndrome (SARS)-associated coronavirus (SARS-CoV) has been identified as the aetiological agent of SARS. We previously isolated and characterized SARS-CoV and SARS-CoV-like viruses from human and animals, respectively, suggesting that SARS could be transmitted from wild/farmed animals to humans. Comparison of the viral genomes indicated that sequence variation between animal and human isolates existed mainly in the spike (S) gene. We hypothesized that these variations may underlie a change of binding specificity of the S protein to the host cells, permitting viral transmission from animals to humans. Here we report that four 20-mer synthetic peptides (S protein fragments), designed to span these sequence variation hotspots, exhibited significant antiviral activities in a cell line. SARS-CoV infectivity was reduced over 10 000-fold through pre-incubation with two of these peptides, while it was completely inhibited in the presence of three peptides. Molecular modelling of the SARS-CoV peplomer suggests that three of these antiviral peptides map to the interfaces between the three monomers of the trimeric peplomer rather than the heptad repeat region from which short peptides are known to inhibit viral entry. Our results revealed novel regions in the spike protein that can be targeted to inhibit viral infection. The peptides identified in this study could be further developed into antiviral drugs.

PubMed Disclaimer

Cited by

Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus.
Chan JF, Chan KH, Kao RY, To KK, Zheng BJ, Li CP, Li PT, Dai J, Mok FK, Chen H, Hayden FG, Yuen KY. Chan JF, et al. J Infect. 2013 Dec;67(6):606-16. doi: 10.1016/j.jinf.2013.09.029. Epub 2013 Oct 3. J Infect. 2013. PMID: 24096239 Free PMC article.
The bright and dark sides of protein conformational switches and the unifying forces of infections.
Sannigrahi A, De N, Chattopadhyay K. Sannigrahi A, et al. Commun Biol. 2020 Jul 15;3(1):382. doi: 10.1038/s42003-020-1115-x. Commun Biol. 2020. PMID: 32669705 Free PMC article. Review.
Adaptive evolution of the spike gene of SARS coronavirus: changes in positively selected sites in different epidemic groups.
Zhang CY, Wei JF, He SH. Zhang CY, et al. BMC Microbiol. 2006 Oct 4;6:88. doi: 10.1186/1471-2180-6-88. BMC Microbiol. 2006. PMID: 17020602 Free PMC article.
Coronaviruses - drug discovery and therapeutic options.
Zumla A, Chan JF, Azhar EI, Hui DS, Yuen KY. Zumla A, et al. Nat Rev Drug Discov. 2016 May;15(5):327-47. doi: 10.1038/nrd.2015.37. Epub 2016 Feb 12. Nat Rev Drug Discov. 2016. PMID: 26868298 Free PMC article. Review.
Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection.
Cheng VC, Lau SK, Woo PC, Yuen KY. Cheng VC, et al. Clin Microbiol Rev. 2007 Oct;20(4):660-94. doi: 10.1128/CMR.00023-07. Clin Microbiol Rev. 2007. PMID: 17934078 Free PMC article. Review.

Synthetic peptides outside the spike protein heptad repeat regions as potent inhibitors of SARS-associated coronavirus - PubMed (original) (raw)